Tcelna FDA Approval Status
FDA Approved: No
Brand name: Tcelna
Generic name: imilecleucel-T
Previous Name: Tovaxin
Company: Opexa Therapeutics, Inc.
Treatment for: Multiple Sclerosis
Tcelna (imilecleucel-T) is a personalized T-cell immunotherapy in development for the treatment of Secondary Progressive Multiple Sclerosis.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
